首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1956163

日本病理檢測服務市場規模、佔有率、趨勢及預測（按類型、檢測服務、最終用途和地區分類），2026-2034年

Japan Pathology Lab Services Market Size, Share, Trends and Forecast by Type, Testing Service, End Use, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 148 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本病理檢測服務市場規模達349.255億美元。 IMARC Group預測，到2034年，該市場規模將達到773.933億美元，2026年至2034年的複合年成長率（CAGR）為9.24%。推動該市場成長的主要因素是數位病理學和人工智慧的快速普及，以及政府推行的數位化醫療轉型和精準醫療政策。人口老化和慢性病的盛行率上升，推動了基因組檢測和個人化診斷的需求，促使實驗室加強次世代定序（NGS）和生物標記分析能力。病理檢測服務供應商、人工智慧Start-Ups和製藥公司之間的策略合作，正在加速創新，並進一步擴大日本病理檢測服務市場的佔有率。

日本病理檢測服務市場的發展趨勢：

數位病理學和人工智慧整合技術的日益普及

市場正經歷著數位化病理學和人工智慧（AI）融合的重大轉變。全切片成像（WSI）技術和雲端資料儲存的進步正推動實驗室從傳統顯微鏡轉向數位平台，從而實現更快、更準確的診斷。人工智慧工具正被擴大用於輔助病理學家檢測異常、減少人為錯誤並簡化工作流程。日本政府大力推動數位化醫療轉型以及對精準醫療日益成長的需求正在加速這一趨勢。為了因應人口老化帶來的病理服務需求成長，日本2024會計年度的數位醫療預算大幅增加，達到617億日圓（約4億美元）。政府尤其重視人工智慧診斷和電子健康記錄（EMR）的實施。根據政府估計，到2040年，日本將面臨96萬名醫療專業人員的缺口，凸顯了在檢測和診斷領域快速採用數位科技的緊迫性。目前，美日合作主要集中在電子病歷標準化、病理學人工智慧開發以及跨境資料交換等方面，旨在實現實驗室基礎設施的數位現代化。此外，病理檢查室與人工智慧Start-Ups的合作正在推動自動化診斷領域的創新，尤其是在癌症檢測領域。然而，高昂的實施成本和資料安全隱患等挑戰依然存在。儘管存在這些障礙，但對擴充性遠距離診斷解決方案日益成長的需求，尤其是在遍遠地區，預計將在未來十年推動日本進一步普及數位病理學。

對基因組檢測和個人化醫療的需求日益成長

基因組檢測和個人化醫療需求的快速成長顯著推動了日本病理檢測服務市場的發展。面對人口老化和慢性病的盛行率上升，基於基因譜分析的個人化治療策略變得日益重要。預計到2032年，日本發炎性腸道疾病（IBD）的發生率將從2022年的每10萬人368.3例增加至645.8例，年均成長率達5.78%，其中18歲以下患者的成長率最高。潰瘍性大腸炎預計仍將是日本最常見的IBD亞型，預計到2032年，其盛行率將達到每10萬人545.9例，超過克隆氏症的101.9例。慢性病盛行率的上升趨勢凸顯了日本IBD醫療體系亟需擴大病理檢測設施並提升兒童診斷能力。病理檢查室正在拓展其在次世代定序(NGS) 和生物標記分析方面的能力，以支持精準癌症治療和罕見疾病診斷。諸如「全民醫療」等政府政策正在推動基因組醫學的發展，進一步加速市場成長。私人實驗室也正與製藥公司合作，開發標靶治療的伴隨診斷。儘管高成本且監管複雜，但向個人化醫療的轉變預計將持續推動日本病理學領域的長期成長，而實驗室將在推進精準醫療方面發揮關鍵作用。

本報告解答的關鍵問題

日本病理檢測服務市場目前表現如何？未來幾年又將如何發展？
日本病理檢測服務市場如何依檢測類型細分？
日本病理檢測服務市場依檢測服務類型分類的組成是怎樣的？
日本病理檢測服務市場以最終用途分類的組成是怎樣的？
日本病理檢測服務市場按地區分類的市場組成是怎樣的？
日本病理檢測服務市場的價值鏈包含哪些階段？
日本病理檢測服務市場的主要促進因素和挑戰是什麼？
日本病理檢測服務市場的結構是怎麼樣的？主要參與者有哪些？
日本病理檢測服務市場的競爭程度如何？

The Japan pathology lab services market size reached USD 34,925.5 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 77,393.3 Million by 2034 , exhibiting a growth rate (CAGR) of 9.24 % during 2026-2034 . The market is driven by the rapid adoption of digital pathology and AI, supported by government initiatives promoting digital healthcare transformation and precision medicine. The increasing number of elderly individuals and the prevalence of chronic illnesses are driving the need for genomic testing and personalized diagnostics, prompting laboratories to enhance their capabilities in next-generation sequencing (NGS) and biomarker analysis. Strategic collaborations between pathology providers, AI startups, and pharmaceutical firms are accelerating innovations, further augmenting the Japan pathology lab services market share.

JAPAN PATHOLOGY LAB SERVICES MARKET TRENDS:

Increasing Adoption of Digital Pathology and AI Integration

The market is witnessing a significant shift toward digital pathology and artificial intelligence (AI) integration. With advancements in whole-slide imaging (WSI) and cloud-based data storage, labs are transitioning from traditional microscopy to digital platforms for faster and more accurate diagnostics. AI-powered tools are being increasingly adopted to assist pathologists in detecting anomalies, reducing human error, and improving workflow efficiency. The Japanese government's push for digital healthcare transformation, along with rising demand for precision medicine, is accelerating this trend. Japan's fiscal year 2024 budget for digital health has risen substantially to JPY 61.7 billion (approximately USD 400 Million), with an emphasis on AI diagnostics and the inclusion of electronic medical records (EMRs) to meet the increased need for pathology services resulting from an aging population. Government estimates predict a shortage of 960,000 healthcare professionals by 2040, which underscores the need for swift implementation of digital technologies in the laboratory and diagnostic sectors. United States-Japan collaborations are now focused on EMR standardization, AI development in pathology, and cross-border data exchange to digitally revamp laboratory infrastructure. Additionally, collaborations between pathology labs and AI startups are fostering innovation in automated diagnosis, particularly in cancer detection. However, challenges such as high implementation costs and data security concerns remain. Despite these barriers, the growing need for scalable and remote diagnostic solutions, especially in rural areas, is expected to drive further adoption of digital pathology in Japan over the next decade.

Rising Demand for Genomic Testing and Personalized Medicine

The accelerating demand for genomic testing and personalized medicine is significantly supporting the Japan pathology lab services market growth. As the nation confronts an increasing elderly population and a higher incidence of chronic illnesses, there is an intensifying emphasis on customized treatment strategies informed by genetic profiling. The incidences of inflammatory bowel disease (IBD) in Japan are projected to be 645.8 per 100,000 by 2032, up from 368.3 in 2022. It will increase at an annual rate of 5.78%, with the highest rise reported in patients under 18 years of age. Ulcerative colitis is also projected to continue being the major subtype in Japan with an estimated prevalence of 545.9 per 100,000 in 2032, higher than Crohn's disease at 101.9. The rising epidemic of chronic illness shows the pressing necessity of upgrading pathology laboratory facilities and upgrading pediatric diagnostic capacity in Japan's IBD care system. Pathology labs are expanding their capabilities to include next-generation sequencing (NGS) and biomarker analysis to support precision oncology and rare disease diagnosis. Government initiatives, such as the "Healthcare Policy for All Citizens," are promoting genomic medicine, further propelling market growth. Private labs are also partnering with pharmaceutical companies to develop companion diagnostics for targeted therapies. Despite the high costs and regulatory complexities, the shift toward personalized healthcare is expected to sustain long-term growth in Japan's pathology sector, with labs playing a crucial role in advancing precision medicine.

JAPAN PATHOLOGY LAB SERVICES MARKET SEGMENTATION:

Type Insights:

Hospital-based
Standalone Labs
Diagnostic Chains

Testing Service Insights:

General Physiological and Clinical Tests
Imaging and Radiology Tests
Esoteric Tests
COVID-19 Tests

End Use Insights:

Physician Referral
Walk-in
Corporate

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the Japan pathology lab services market performed so far and how will it perform in the coming years?
What is the breakup of the Japan pathology lab services market on the basis of type?
What is the breakup of the Japan pathology lab services market on the basis of testing service?
What is the breakup of the Japan pathology lab services market on the basis of end use?
What is the breakup of the Japan pathology lab services market on the basis of region?
What are the various stages in the value chain of the Japan pathology lab services market?
What are the key driving factors and challenges in the Japan pathology lab services market?
What is the structure of the Japan pathology lab services market and who are the key players?
What is the degree of competition in the Japan pathology lab services market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pathology Lab Services Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Pathology Lab Services Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Pathology Lab Services Market - Breakup by Type

6.1 Hospital-based
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Standalone Labs
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Diagnostic Chains
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Pathology Lab Services Market - Breakup by Testing Service

7.1 General Physiological and Clinical Tests
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Imaging and Radiology Tests
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Esoteric Tests
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 COVID-19 Tests
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)

8 Japan Pathology Lab Services Market - Breakup by End Use

8.1 Physician Referral
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Walk-in
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Corporate
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)

9 Japan Pathology Lab Services Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Type
- 9.1.4 Market Breakup by Testing Service
- 9.1.5 Market Breakup by End Use
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Type
- 9.2.4 Market Breakup by Testing Service
- 9.2.5 Market Breakup by End Use
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Type
- 9.3.4 Market Breakup by Testing Service
- 9.3.5 Market Breakup by End Use
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Type
- 9.4.4 Market Breakup by Testing Service
- 9.4.5 Market Breakup by End Use
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Type
- 9.5.4 Market Breakup by Testing Service
- 9.5.5 Market Breakup by End Use
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Type
- 9.6.4 Market Breakup by Testing Service
- 9.6.5 Market Breakup by End Use
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Type
- 9.7.4 Market Breakup by Testing Service
- 9.7.5 Market Breakup by End Use
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Type
- 9.8.4 Market Breakup by Testing Service
- 9.8.5 Market Breakup by End Use
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Pathology Lab Services Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Pathology Lab Services Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis